Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Membership
    • Membership Overview
      • Become a Member
      • Member Testimonials
    • Member Resources
      • My Dashboard
      • Manage My Education
      • Renew My Membership
      • Member Center
      • Find a Mentorship
      • Councils & Committees
      • Volunteer Opportunities
      • Awards & Recognition
      • Member Rewards
      • Lab Week
      • ASCP News
      • ASCP Local Chapters
    • My Role
      • Pathologist
      • Laboratory Professional
      • Pathology Resident
      • Residency Program Director
      • Lab Sciences Program Director
      • Laboratory Science Student
      • Medical Student
    • Career Resources
      • Find a Job
      • Post a Job
      • Find a Pathology Fellowship
      • Post a Fellowship
      • Learn About Careers
      • Scholarships & Grants
  • Learning
    • Learning Overview
    • Certificate Programs
      • Lab Management University
      • University of Path Informatics
      • Leadership Institute
    • Live Events
      • ASCP Annual Meeting
      • Virtual Pathology Grand Rounds
      • KnowledgeLab
      • Immersion Courses
    • Resources
      • Access My Education
      • Manage CMP
      • Manage CC
    • ASCPedia
    • Online Education
      • Online CE Packages
      • LabQ
      • Case Reports
      • Resident Question Bank (RQB)
      • MLS Online Review Course
      • Webcasts
      • Patient Safety
      • Featured Education
    • Quality Improvement & Quality Assurance
      • Continuous Quality Improvement (CQI)
      • National Pathology Quality Registry (NPQR)
      • CheckPath
      • GYN Assessment
      • Non-GYN Assessment
      • GYN Proficiency Testing
    • Books & Journals
      • Books
      • American Journal of Clinical Pathology (AJCP)
      • Lab Medicine
      • Critical Values
    • ACCME ACCREDITATION
  • Advocacy & Outreach
    • Institute For Science Technology, and Public Policy
      • ASCP Policy Efforts
      • Choosing Wisely
      • Guidelines & Resources
      • Workforce Initiatives
      • ePolicy News
    • Center For Global Health
      • Overview
      • Communicable Diseases (HIV)
      • Non-Communicable Diseases (Cancer)
      • Volunteer with CGH
    • ASCP Foundation
      • Make a Donation
      • Providing Scholarships, Grants, & Fellowships
      • Improving Global Health
      • Increasing Lab Visibility
      • ASCP General Fund
      • Ways to Donate
    • Get Involved
      • Discover Opportunities to Get Involved
      • Foster Diversity & Inclusion
      • ASCP Councils & Committees
      • Career Ambassadors
      • Pathology Ambassadors
      • Discover Mentorships
      • Apply to Volunteer
    • Laboratory Excellence
      • Leading Laboratories
      • National Pathology Quality Registry (NPQR)
      • Awards & Recognition
      • Lab Week
    • Patient Champions
  • About ASCP
    • About ASCP
      • ASCP Mission
      • Supporting Our Members
      • ASCP Foundation
      • Community Efforts
      • Work at ASCP
    • Contact Us
  • Board of Certification
    • BOC home
    • About The BOC
      • About the BOC
        • BOC Structure
          • BOC Mission
          • BOC Partners
          • Contact BOC
          • Appeals
        • News and Reports
          • Transition of MT/MLS and MP/MB
          • Newsletters
          • BOC Awards
          • Lab Hero Interviews
          • Statistics / Practice Analyses
      • What We Do
        • Our Services
          • Certs & Quals
          • CMP
          • Verify Credentials
      • Governance
        • Committees
          • Exam Committee
          • Board of Governors
        • International Governance
          • Advisory Boards
          • Collaborating Societies
      • Volunteer
        • Volunteer Opportunities
          • Exam Committees
          • International Volunteer Opportunities
          • ASCP
    • Get Credentialed
      • Certification Exam Process
        • Get Ready to Apply
          • General Information
          • Determine Category & Route
          • Compare US & International Certification
        • Gather Documentation
          • US Certification
          • International Certication
          • US Military
        • Before Exam
          • Schedule a Date
          • Study Materials
        • Exam Day
          • The Test Center
          • The Examination
        • After Exam
          • Pass The Exam
          • Fail The Exam
      • U.S. Certifications
        • Highest Volume
          • HT
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLA
          • MLT
          • PBT
          • DPT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CT
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
        • Additional
          • DLM
          • PA
      • International Certifications
        • Highest Volume
          • MB
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLT
          • PBT
        • Technologist/Scientists
          • BB
          • MB
          • MLS
          • C
          • CG
          • CLM
          • CT
          • CTGYN
          • H
          • HLT
          • M
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
      • Qualifications
        • Get Ready to Apply
          • General Information
          • Determine Category and Exam Route
          • Gather Document
        • Examination
          • Take the Exam
          • Pass the Exam
          • Fail the Exam
        • Qualifications
          • QBRS
          • QDP
          • QIA
          • QIHC
          • QLS
      • State Licensure
        • California State Licensure
          • California State Licensure Only
          • ASCP Certification & CA Licensure
          • Already ASCP Certified
        • New York State Licensure
          • New York State Licensure Only
          • ASCP Certification & NY Licensure
          • Already ASCP Certified
        • Additional Licensure States
          • Florida
          • Hawaii
          • Louisiana
          • Montana
          • Nevada
          • North Dakota
          • Tennesee
          • West Virginia
          • Puerto Rico
    • Stay Credentialed
      • Information About CMP
        • CMP Overview
          • CMP Process
          • Synchronize Multiple Credentials
        • Credential Status
          • Mandatory
          • Voluntary
          • Expired
          • Inactive
        • How to Manage Points
          • How to Earn Points
          • How to Record Points
          • Suggested CE Providers
          • When to Submit a Declaration
          • COVID Related CE Form
      • U.S. Certifications
        • Highest Volume
          • HT
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLA
          • MLT
          • PBT
          • AT
          • DPT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CT
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
          • HP
          • SLS
          • SV
        • Additional
          • DLM
          • PA
      • International Certifications
        • Highest Volume
          • MB
          • MLS
          • MLT
          • PBT
        • Technician
          • HT
          • MLT
          • PBT
        • Technologist/Scientists
          • BB
          • C
          • CG
          • CLM
          • CT
          • CTGYN
          • H
          • HTL
          • M
          • MB
          • MLS
        • Specialist
          • SBB
          • SC
          • SCT
          • SCYM
          • SH
          • SM
          • SMB
      • Qualifications
        • Qualifications
          • QBRS
          • QDP
          • QIA
          • QIHC
          • QLI
          • QLS
    • Verify Credentials
      • General Information
        • Topics
          • Citation of Credentials
          • Fraudulent Use of Credentials
          • Replacement Wall Certificates
      • How to Verify
        • Options for Verifying Credentials
          • Getting Started
          • For Certification/Qualification
          • For State Licensure
          • For Visa Screen
          • Place an Order
    • Program Directors
      • Program Director Resources
        • Resources
          • BOC Resources
          • Accreditation Agencies
      • Manage Your Students
        • Tools & Reports
          • Tools for Students
          • EEV
          • PPR
      • Certification Information
        • Exams Offered
          • Certification Exams
          • HT/HTL
          • Military Certifications
          • Phlebotomy Programs
  • News
  • News
  • News Archive
  • Groups
  • Jobs
  • ASCP
  • News Archive
  • News Detail

HHS Orders FDA to Resume EUA Review of COVID-19 Lab Developed Tests—And Fast

Publication Date: Dec 7, 2020

The controversy over FDA Emergency Use Authorization (EUA) of laboratory developed tests (LDTs) for COVID-19 is on high boil once more. A month after the agency announced it would no longer review such tests, the Department of Health and Human Services (HHS) has countermanded that decision, ordering the FDA to resume LDT EUA applications and do it in a “timely manner.” The new HHS mandate is the latest and perhaps most decisive twist in what has become a somewhat bizarre battle within the administration over regulation of LDTs that has sparked up during the public health emergency.

The Controversy Over COVID-19 LDTs

Some of the earliest, most innovative and important new COVID-19 tests to receive EUA in the early days of the pandemic were LDTs created by testing companies, universities and medical centers, including molecular and antibody assays, as well as saliva and home-collection products. The demonstrated ability of labs to step up and meet the unprecedented demand for new COVID-19 tests seemed to vindicate the decades-old case for relaxing FDA regulation in the interest of innovation and public health. 

The other impetus to rapid change was the current administration’s general policy of cutting regulatory red tape for business. Historically protective of its regulatory authority over LDTs, the FDA needed a little prodding to loosen the reins. That prodding came on August 19 when the HHS announced that the FDA would no longer require premarket review for LDTs but that labs could still seek EUA voluntarily. In addition, the FDA would now have to use the notice and rulemaking process to create new rules and could no longer regulate LDTs via website notices and other informal methods.

On October 7, the FDA fired back by announcing that it was bowing out of EUA review for any LDTs to “make the best use” of its review resources and prioritize “innovative, high-throughput [tests] that have reduced reliance on supplies and been integral to expanding testing capacity.” It was a head scratching decision to the extent that the COVID-19 tests that passed through the EUA pipeline were precisely the types of products the FDA’s new policy purported to promote.

The decision, which applied not just to new submissions but also to LDT EUA applications already in the pipeline, threatened to chill LDT development by stripping labs of crucial liability protections. While supportive of the initial HHS policy, the lab industry criticized the FDA decision and called on the agency to continue to let labs continue to voluntarily seek EUA for COVID-19 LDTs.

HHS Orders FDA to Resume EUA Review

The most recent twist came on November 16 when HHS Assistant Secretary for Health and White House coronavirus testing czar Brett Giroir ordered the FDA to resume EUA review of COVID-19 LDTs, and do it fast. The agency’s orders are to clear the backlog of submissions created by its decision to cease review within 14 days. If, as is highly likely to prove the case, the FDA can’t meet that deadline, the National Cancer Institute (NCI) will step in to help.

“We recognize the FDA has a huge workload,” Giroir noted. “That’s why we’re trying to provide additional resources. I don't think anybody can question the scientific integrity of the NCI.”   

What’s At Stake

The reason the HHS has chosen to intervene is the fear that labs won’t create new LDTs for COVID-19 unless they can secure EUA because of potential liability exposure if the product doesn’t work as planned. Explanation: Normally, new diagnostics and medical products must undergo long and extensive clinical review before they can reach the market. But in times of public health emergency, it becomes necessary to accelerate the standard review protocols. The upside of abbreviated vetting is that products become available faster; the downside is that they carry greater than normal risks to users. Accordingly, producers are at higher risk of being sued for products liability.

To ensure that fear of liability doesn’t chill innovation, a federal law called the Public Readiness and Emergency Preparedness Act (PREP) provides immunity to test makers and other producers that create medical products in response to a public health emergency. The FDA decision not to perform EUA review of LDTs for COVID-19 effectively strips test makers of their PREP immunity and makes them a sitting duck for trial lawyers and products liability lawsuits.

Giroir acknowledged that this was behind the order for FDA to resume EUA review of COVID-19 LDTs, noting on a media call that “without an EUA, although the tests can be used, they cannot receive liability protection under the PREP Act.” Giroir added that the goal is to ensure that universities and other LDT makers are “given the same liability protection as major corporate developers and manufacturers.”

**************

This article originally appeared in G2 Intelligence, Laboratory Industry Report, December 2020

Footer
  • Membership
    • Membership Overview
    • Member Resources
    • My Role
    • Career Resources
  • Learning
    • Online Education
    • Certificate Programs
    • Quality Improvement & Quality Assurance
    • Live Events
    • Books & Journals
    • Resources
    • ASCPedia
    • ACCME Accreditation
  • Advocacy & Outreach
    • Institute for Science, Technology, and Public Policy
    • Center for Global Health
    • ASCP Foundation
    • Patient Champions
    • Get Involved
  • About ASCP
    • Contact Us
    • Chat with Us
  • Board Of Certification
    • Get Credentialed
    • Stay Credentialed
    • Verify Credentials
    • Program Directors
    • About the BOC
  • News
    • ePolicy News
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Live Chat

First Name*
Last Name*
Email*
Customer ID